MLLT3 and acute myeloid leukemia: We here provide evidence that SMAD1 expression is lost or reduced in the majority of AML patient samples and seven AML cell lines, harboring KMT2A::MLLT3 and KMT2A::AFF1 fusion genes (three cell lines with reduced and four with absent SMAD1 expression).